What is Ainos, Inc.'s earnings per share (EPS)?

Ainos, Inc. (AIMD) reported diluted earnings per share of -$3.46 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ainos, Inc. (AIMD) Financials

AIMD

Trailing 12 months to June 30, 2026

Revenue $14K YoY not available

Net Income -$14.5M YoY not available

EPS (Diluted) -$3.46 FY2025 annual

Free Cash Flow -$4.5M +9.4% YoY

Market Cap $8.9M as of Oct 9, 2026

Price / Sales 657x on $14K revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 2.7x on $3.3M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 3, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AIMD SEC filings page.

Ainos, Inc. (AIMD) reported $14K in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIMD FY2025 2026-10-03

Ainos remains development-stage: FY2025 revenue was $124K against $14.1M of R&D and overhead, leaving operations dependent on financing.

In FY2025, R&D and SG&A totaled $14.1M against revenue of $124K, showing costs remain far ahead of commercial scale. Operating cash flow of -$4.6M confirms that gap is cash-consuming, not merely an accounting presentation.

Debt-to-equity increased from 0.3x in FY2023 to 1.8x in FY2025, showing financing claims became more prominent relative to book equity as the business absorbed losses. FY2025 equity was $7.6M and the current ratio was 1.1x, so near-term assets roughly matched obligations while the broader capital cushion narrowed.

FY2025 free cash flow was -$4.6M despite only $35K of capital expenditures, which means the cash drain primarily reflects ongoing operations rather than heavy reinvestment. Reported liquidity equaled 1.1 months of latest annual operating outflow, while financing cash flow supplied $1.0M; that pairing indicates external funding was offsetting operating cash use.

Financial Health Signals

Financial health score not available

Ainos, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-6.33

Ainos, Inc. scores -6.33, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($8.9M) relative to total liabilities ($13.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

Ainos, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Ainos, Inc. reported a net loss of $14.8M while operations used $4.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Ainos, Inc. reported an operating loss of $14.0M against $712K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$152

YoY-96.7%

QoQ-5.6%

Ainos, Inc. generated $152 in revenue in Q2 2026. This represents a decrease of 96.7% from the same quarter a year earlier. Against the prior quarter it is down 5.6%.

EBITDA

-$3.2M

YoY-25.9%

QoQ-189.6%

Ainos, Inc.'s EBITDA was -$3.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.9% from the same quarter a year earlier. Against the prior quarter it is down 189.6%.

Net Income

-$4.6M

YoY-12.5%

QoQ-86.8%

Ainos, Inc. reported -$4.6M in net income in Q2 2026. This represents a decrease of 12.5% from the same quarter a year earlier. Against the prior quarter it is down 86.8%.

EPS (Diluted)

-$0.62

QoQ-51.2%

Ainos, Inc. earned -$0.62 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 51.2%.

Cash & Balance Sheet

Free Cash Flow

-$1.5M

YoY-7.1%

QoQ-46.6%

Ainos, Inc. recorded an outflow of $1.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 7.1% from the same quarter a year earlier. Against the prior quarter it is down 46.6%.

Cash & Debt

$1.4M

YoY+16.3%

QoQ-49.9%

5Y CAGR+18.6%

10Y CAGR+16.4%

Ainos, Inc. held $1.4M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

QoQ-13.4%

5Y CAGR-44.7%

10Y CAGR-10.1%

Ainos, Inc. had 7M shares outstanding in Q2 2026. Against the prior quarter it is down 13.4%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

65.1%

YoY-14.8pp

Ainos, Inc.'s gross margin was 65.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 14.8 percentage points from the same quarter a year earlier.

Return on Equity

-139.9%

YoY-104.2pp

QoQ-96.7pp

Ainos, Inc.'s ROE was -139.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 104.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 96.7 percentage points.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$1.9M

YoY-3.2%

QoQ+9.5%

Ainos, Inc. invested $1.9M in research and development in Q2 2026. This represents a decrease of 3.2% from the same quarter a year earlier. Against the prior quarter it is up 9.5%.

Capital Expenditures

$6K

YoY-24.8%

QoQ-32.3%

Ainos, Inc. invested $6K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 24.8% from the same quarter a year earlier. Against the prior quarter it is down 32.3%.

Share Buybacks

Not reported for Q2 2026.

AIMD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIMD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$14K	$124K+499.0%	$21K-83.0%	$122K-96.5%	$3.5M+492.0%	$595K+3489.7%	$17K+41.2%	$12K-84.9%	$78K-69.0%	$251K	N/A	$0	$0	$0-100.0%	$530-99.1%	$58K
Cost of Revenue	$3K	$21K-59.6%	$53K-86.0%	$376K-82.2%	$2.1M+1047.9%	$184K+1533.2%	$11K+28.6%	$9K-86.5%	$65K+7.6%	$60K	N/A	N/A	N/A	N/A	$212-95.1%	$4K
Gross Profit	$11K	$103K+422.9%	-$32K+87.4%	-$254K-118.1%	$1.4M+242.4%	$410K+7663.6%	$5K+78.6%	$3K-77.0%	$13K-93.3%	$191K	N/A	N/A	N/A	N/A	$318-99.4%	$54K
R&D Expenses	$7.7M	$7.7M-7.9%	$8.4M+15.0%	$7.3M+6.9%	$6.8M+256.4%	$1.9M+493639.1%	$389-99.3%	$53K+61.1%	$33K	N/A	N/A	N/A	N/A	$133K-33.4%	$200K-29.0%	$281K
SG&A Expenses	$6.1M	$6.3M+17.6%	$5.4M-4.3%	$5.6M-34.0%	$8.5M+262.1%	$2.4M	N/A	$1.5M+16.4%	$1.3M+70.7%	$770K+15.5%	$667K+28.3%	$520K	N/A	$433K+21.9%	$355K	N/A
Operating Income	-$13.8M	-$14.0M-1.1%	-$13.8M-4.8%	-$13.2M+5.5%	-$14.0M-261.4%	-$3.9M	N/A	-$1.6M-18.4%	-$1.3M-130.2%	-$580K+13.1%	-$667K-28.3%	-$520K	N/A	-$566K-2.1%	-$555K	N/A
EBITDA	N/A	-$9.2M-1.9%	-$9.0M-8.4%	-$8.3M+8.8%	-$9.1M-401.5%	-$1.8M	N/A	-$1.6M-21.9%	-$1.3M-136.9%	-$540K+15.8%	-$641K-28.2%	-$500K	N/A	-$550K-2.0%	-$539K	N/A
Interest Expense	$731K	$712K+15.5%	$616K+327.5%	$144K+169.4%	$54K+186.4%	$19K+74.6%	$11K+1109.3%	$885-77.7%	$4K-89.5%	$38K+1210.1%	$3K+39.8%	$2K	N/A	$103K-33.6%	$156K-26.5%	$212K
Income Tax	N/A	$8000.0%	$8000.0%	$800	$0	N/A	$0	$0	N/A	N/A	$0	$0	N/A	N/A	N/A	N/A
Net Income	-$14.5M	-$14.8M+0.6%	-$14.9M-7.9%	-$13.8M+1.7%	-$14.0M-260.2%	-$3.9M	N/A	-$1.6M-18.1%	-$1.3M-116.8%	-$617K+7.9%	-$670K-28.4%	-$522K	N/A	-$623K	N/A	N/A
EPS (Basic)	N/A	-$3.46+55.8%	-$7.82-132.7%	-$3.36	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.02
EPS (Diluted)	—	-$3.46	-$7.82	-$3.36	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.010.0%	-$0.01+50.0%	-$0.02
Diluted Shares (Avg)	N/A	4M	2M	4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	73M+0.1%	73M+12.8%	65M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$152-96.7%	$161-99.8%	$11K	$2K	$5K	$106K+412.4%	N/A	N/A
Cost of Revenue	$53-94.3%	$763-95.8%	$2K	$477-12.8%	$937-96.3%	$18K-31.8%	N/A	$547-99.4%
Gross Profit	$99-97.3%	-$602-100.7%	$10K	$2K+409.0%	$4K+114.7%	$88K+1560.1%	N/A	-$547+99.1%
R&D Expenses	$1.9M-3.2%	$1.7M-2.0%	$2.1M	$2.0M-1.6%	$1.9M-3.4%	$1.7M-17.3%	N/A	$2.0M+18.2%
SG&A Expenses	$2.5M+38.7%	$593K-61.1%	$2.2M	$795K-21.7%	$1.8M+75.9%	$1.5M+48.3%	N/A	$1.0M+12.6%
Operating Income	-$4.4M-17.4%	-$2.3M+27.8%	-$4.3M	-$2.8M+8.4%	-$3.7M-22.8%	-$3.2M-1.4%	N/A	-$3.0M-13.6%
EBITDA	-$3.2M-25.9%	-$1.1M+44.1%	-$3.1M	-$1.6M+13.6%	-$2.6M-37.8%	-$2.0M-3.5%	N/A	-$1.8M-26.4%
Interest Expense	$200K+12.5%	$177K-2.0%	$177K	$177K-33.3%	$178K+49.8%	$180K+270.6%	N/A	$265K+497.8%
Net Income	-$4.6M-12.5%	-$2.5M+25.1%	-$4.5M	-$2.9M+20.8%	-$4.1M-27.9%	-$3.3M+0.9%	N/A	-$3.7M-24.3%
EPS (Basic)	-$0.62+37.4%	-$0.41+60.6%	-$0.85-226.9%	-$0.64+61.0%	-$0.99+59.6%	-$1.04-82.5%	-$0.26+81.6%	-$1.64-124.7%
EPS (Diluted)	-$0.62	-$0.41	-$0.85	-$0.64	-$0.99	-$1.04	-$0.26+81.6%	-$1.64
Diluted Shares (Avg)	7M	6M	N/A	5M	4M	3M	N/A	2M

Not reported in any period shown, so not listed: Income Tax.

AIMD Balance Sheet

AIMD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$20.9M-27.6%	$28.8M-9.5%	$31.8M-14.2%	$37.1M-9.1%	$40.8M+15583.3%	$260K-56.4%	$597K-59.2%	$1.5M-36.2%	$2.3M+395.8%	$463K+294.8%	$117K-72.2%	$422K+161.0%	$162K+40.4%	$115K0.0%	$115K
Current Assets	$1.1M-73.7%	$4.3M+75.4%	$2.5M-13.1%	$2.8M+28.3%	$2.2M+2802.3%	$76K-82.8%	$445K-65.8%	$1.3M-37.5%	$2.1M+694.4%	$262K+567.8%	$39K-88.3%	$335K+389.7%	$68K+227.2%	$21K+122.5%	$9K
Cash & Equivalents	$417K-89.3%	$3.9M+106.5%	$1.9M+1.7%	$1.9M+5.8%	$1.8M+7773.7%	$22K-94.6%	$409K-68.0%	$1.3M-37.4%	$2.0M+1419.6%	$134K+534.5%	$21K-93.4%	$319K+4771.6%	$7K-9.9%	$7K+157.6%	$3K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$296K+105.6%	$144K-14.2%	$168K-71.8%	$595K	$0	$0-100.0%	$4K	N/A	$23K+54.2%	$15K	$0	$0	N/A	N/A	N/A
Accounts Receivable	$22-60.7%	$56-87.7%	$455-99.8%	$202K	$0	$0	N/A	N/A	$0	$0	$0	$0	$0	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$13.3M0.0%	$13.3M+79.9%	$7.4M+198.0%	$2.5M-91.9%	$30.6M+2687.7%	$1.1M+45.8%	$753K+2.7%	$734K-59.8%	$1.8M+43.3%	$1.3M+116.0%	$589K+30.3%	$452K-90.9%	$4.9M+16.5%	$4.2M+0.6%	$4.2M
Current Liabilities	$1.1M-72.7%	$4.0M+195.8%	$1.3M-45.9%	$2.5M-91.9%	$30.6M+2685.0%	$1.1M+45.8%	$753K+2.7%	$734K-59.8%	$1.8M+43.3%	$1.3M+116.0%	$589K+94.9%	$302K-93.9%	$4.9M+16.5%	$4.2M+0.6%	$4.2M
Non-Current Liabilities	$12.2M+30.8%	$9.3M+54.3%	$6.1M+74719.5%	$8K-73.2%	$30K	$0	$0	$0	$0	$0	$0-100.0%	$150K	$0	$0	$0
Total Equity	$7.6M-51.3%	$15.5M-36.5%	$24.4M-29.4%	$34.6M+239.6%	$10.2M+1316.4%	-$838K-435.0%	-$157K-121.5%	$730K+55.1%	$471K+158.1%	-$810K-71.6%	-$472K-1435.5%	-$31K+99.4%	-$4.8M-15.9%	-$4.1M-0.6%	-$4.1M
Retained Earnings	-$67.5M-28.0%	-$52.7M-39.2%	-$37.9M-57.1%	-$24.1M-138.6%	-$10.1M-62.5%	-$6.2M-30.4%	-$4.8M-49.6%	-$3.2M-69.2%	-$1.9M-48.7%	-$1.3M-112.3%	-$597K-698.2%	-$75K-100.2%	$32.0M+186.8%	-$36.8M-1.9%	-$36.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$19.6M-18.2%	$22.1M-16.2%	$20.9M-27.6%	$22.7M-27.7%	$23.9M-32.7%	$26.4M-11.4%	$28.8M-9.5%	$31.4M-7.4%
Current Assets	$2.2M+26.2%	$3.5M+15.4%	$1.1M-73.7%	$1.7M-69.5%	$1.7M-79.5%	$3.1M+102.1%	$4.3M+75.4%	$5.6M+85.8%
Cash & Equivalents	$1.4M+16.3%	$2.8M+8.1%	$417K-89.3%	$1.1M-78.1%	$1.2M-84.7%	$2.6M+155.0%	$3.9M+106.5%	$5.2M+117.5%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$309K+92.9%	$316K+122.5%	$296K+105.6%	$167K+3.8%	$160K-3.8%	$142K-16.4%	$144K-14.2%	$161K-26.1%
Accounts Receivable	N/A	$23-74.7%	$22-60.7%	$62	$187+1977.8%	$91-97.8%	$56-87.7%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$16.3M+30.4%	$16.4M+23.9%	$13.3M0.0%	$12.6M-5.3%	$12.5M-15.8%	$13.2M+87.0%	$13.3M+79.9%	$13.3M+116.0%
Current Liabilities	$16.3M+2600.4%	$6.3M+316.6%	$1.1M-72.7%	$581K-85.9%	$603K-89.5%	$1.5M-67.6%	$4.0M+195.8%	$4.1M+404.1%
Non-Current Liabilities	$0-100.0%	$10.0M-14.2%	$12.2M+30.8%	$12.1M+30.8%	$11.9M+30.7%	$11.7M+394.1%	$9.3M+54.3%	$9.2M+72.0%
Total Equity	$3.3M-71.3%	$5.7M-56.6%	$7.6M-51.3%	$10.0M-44.3%	$11.4M-44.8%	$13.1M-42.1%	$15.5M-36.5%	$18.0M-34.9%
Retained Earnings	-$74.6M-24.0%	-$70.0M-24.9%	-$67.5M-28.0%	-$63.1M-31.1%	-$60.1M-35.4%	-$56.0M-36.0%	-$52.7M-39.2%	-$48.1M-50.5%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

AIMD Cash Flow Statement

AIMD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$4.5M	-$4.6M+20.5%	-$5.8M-23.7%	-$4.7M-54.4%	-$3.0M-143.3%	-$1.2M-150.2%	-$500K+45.1%	-$909K+9.9%	-$1.0M-108.3%	-$485K+7.0%	-$521K-42.1%	-$366K	N/A	-$664K-35.7%	-$489K-58.0%	-$310K
Depreciation & Amortization	N/A	$4.8M-0.4%	$4.8M-1.4%	$4.9M+0.8%	$4.8M+136.4%	$2.0M+13809.7%	$15K-33.9%	$22K-60.4%	$56K+40.5%	$40K+54.1%	$26K+31.3%	$20K	N/A	$16K+3.5%	$16K-6.2%	$17K
Stock-Based Compensation	N/A	$1.7M-51.2%	$3.5M+217.8%	$1.1M-82.6%	$6.4M+60213.1%	-$11K-107.1%	$150K	$0-100.0%	$100K-5.5%	$106K	$0	N/A	N/A	N/A	$2K-99.6%	$422K
Capital Expenditures	$23K	$35K+62.0%	$21K-77.1%	$93K-85.3%	$634K+340.8%	$144K	$0-100.0%	$2K-66.6%	$5K	N/A	$48K+573.4%	$7K	N/A	N/A	N/A	N/A
Free Cash Flow	-$4.5M	-$4.6M+20.2%	-$5.8M-21.8%	-$4.8M-30.3%	-$3.7M-163.6%	-$1.4M-179.0%	-$500K+45.2%	-$911K+10.2%	-$1.0M	N/A	-$568K-52.2%	-$373K	N/A	N/A	N/A	N/A
Investing Cash Flow	$23K	-$2K+98.2%	-$125K-23.4%	-$102K+83.9%	-$630K-249.1%	-$181K-2392.3%	-$7K+44.7%	-$13K-80.1%	-$7K+85.2%	-$49K+66.9%	-$148K-1181.1%	-$12K	N/A	-$15K-269.6%	-$4K-45.1%	-$3K
Financing Cash Flow	$4.7M	$1.0M-87.4%	$8.0M+63.0%	$4.9M+27.9%	$3.9M+22.1%	$3.2M+2528.6%	$120K+118.3%	$55K-78.4%	$255K-89.5%	$2.4M+211.7%	$782K+870.7%	$81K	N/A	$679K+36.3%	$498K+60.1%	$311K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$500	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$1.4M-7.3%	-$983K+19.7%	-$855K+1.1%	-$1.2M+19.7%	-$1.4M+31.6%	-$1.2M+18.1%	-$864K+37.1%	-$1.5M-98.5%
Depreciation & Amortization	$1.2M-0.7%	$1.2M-0.3%	$1.2M+0.9%	$1.2M-0.4%	$1.2M-0.3%	$1.2M-2.0%	$1.2M-2.1%	$1.2M-1.5%
Stock-Based Compensation	$2.0M+51.9%	N/A	N/A	$348K-26.0%	$1.3M+213.6%	$55K-87.0%	N/A	$471K+44.9%
Capital Expenditures	$6K-24.8%	$9K-74.6%	-$2K+68.4%	$10K-0.1%	-$8K+31.5%	$34K+659.7%	$908-93.9%	$10K-72.3%
Free Cash Flow	-$1.5M-7.1%	-$992K+21.2%	-$857K+1.0%	-$1.2M+19.6%	-$1.4M+31.4%	-$1.3M+16.1%	-$865K+37.7%	-$1.5M-90.4%
Investing Cash Flow	$7K+190.2%	-$79+99.6%	$11K-18.0%	$5K+126.3%	$3K+129.9%	-$21K+81.5%	$13K-17.0%	-$19K+59.4%
Financing Cash Flow	$0+100.0%	$3.4M+23279.3%	$156K+157.7%	$1.1M+176.5%	-$296K-103.3%	$15K-98.1%	-$270K-130.0%	-$1.5M-180.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AIMD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIMD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	82.9%	-153.7%	-207.8%	39.9%-29.1pp	69.0%+37.1pp	31.9%+6.7pp	25.2%+8.7pp	16.5%-59.4pp	76.0%	N/A	N/A	N/A	N/A	60.0%-32.5pp	92.5%
Operating Margin	-11268.3%	-66772.2%	-10815.0%	-397.1%	-650.5%	N/A	-13472.1%	-1717.2%	-231.1%	N/A	N/A	N/A	N/A	-104643.0%	N/A
Net Margin	-11897.0%	-71702.3%	-11277.0%	-398.0%	-654.0%	N/A	-13479.7%	-1722.3%	-246.0%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-195.3%-99.5pp	-95.8%-39.5pp	-56.3%-15.9pp	-40.5%-2.3pp	-38.1%	N/A	N/A	-183.4%-52.2pp	-131.1%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-70.8%-19.2pp	-51.6%-8.3pp	-43.3%-5.5pp	-37.7%-28.2pp	-9.5%	N/A	-265.0%-173.6pp	-91.5%-64.5pp	-26.9%+117.9pp	-144.8%+300.5pp	-445.3%	N/A	-385.4%	N/A	N/A
Current Ratio	1.060.0x	1.10-0.8x	1.85+0.7x	1.15+1.1x	0.070.0x	0.07-0.5x	0.59-1.2x	1.78+0.6x	1.14+0.9x	0.21+0.1x	0.07-1.0x	1.11+1.1x	0.010.0x	0.000.0x	0.00
Debt-to-Equity	1.76+0.9x	0.86+0.6x	0.30+0.2x	0.07-2.9x	3.00	N/A	N/A	1.00-2.9x	3.87	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.010.0x	0.000.0x	0.00-0.1x	0.09+0.1x	0.010.0x	0.060.0x	0.020.0x	0.05-0.1x	0.11	N/A	0.000.0x	0.000.0x	0.000.0x	0.00-0.5x	0.51
FCF Margin	-3744.7%	-28122.9%	-3920.7%	-104.4%	-234.4%	-3016.1%	-7766.7%	-1304.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	65.1%-14.8pp	-373.9%	85.6%	78.0%	79.9%	82.8%+111.9pp	N/A	N/A
Operating Margin	-2894135.5%	-1418414.3%	-38648.0%	-128481.4%	-80327.8%	-2978.0%	N/A	N/A
Net Margin	-3022849.3%	-1527826.1%	-40182.5%	-135288.5%	-87604.3%	-3094.0%	N/A	N/A
Return on Equity	-139.9%-104.2pp	-43.2%-18.2pp	-59.1%	-29.2%-8.7pp	-35.7%-20.3pp	-25.0%-10.4pp	N/A	-20.5%-9.8pp
Return on Assets	-23.5%-6.4pp	-11.1%+1.3pp	-21.4%	-12.9%-1.1pp	-17.1%-8.1pp	-12.5%-1.3pp	N/A	-11.8%-3.0pp
Current Ratio	0.13-2.7x	0.55-1.4x	1.060.0x	2.96+1.6x	2.88+1.4x	2.00+1.7x	1.10-0.8x	1.37-2.3x
Debt-to-Equity	4.96+3.9x	2.88+1.9x	1.76+0.9x	1.26+0.5x	1.09+0.4x	1.01+0.7x	0.86+0.6x	0.74+0.5x
Asset Turnover	0.000.0x	0.000.0x	0.00	0.00	0.00	0.000.0x	N/A	N/A
FCF Margin	-956653.3%	-616126.1%	-7702.8%	-55137.0%	-29125.3%	-1184.7%	N/A	N/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ainos, Inc. AIMD	FY2025	$124K	-$14.8M	N/A	$8.9M	—
Intelligent Bio Solutions Inc. INBS	FY2026	$4.2M	-$12.4M	N/A	$5.1M	40/100
ALLURION TECHNOLOGIES ALUR	FY2025	$15.2M	-$28.8M	N/A	$10.0M	—
Trinity Biotech plc TRIB	FY2025	$43.8M	$1.9M	4.4%	$5.6M	26/100
enVVeno Medical Corporation NVNO	FY2025	N/A	-$19.5M	N/A	$6.1M	—
Nexalin Technology, Inc. NXL	FY2025	$302K	-$8.2M	N/A	$3.8M	—

Where Ainos, Inc. Ranks

Frequently Asked Questions

What is Ainos, Inc.'s annual revenue?

Ainos, Inc. (AIMD) reported $124K in total revenue for fiscal year 2025. This represents a 499.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ainos, Inc.'s revenue growing?

Ainos, Inc. (AIMD) revenue grew by 499.0% year-over-year, from $21K to $124K in fiscal year 2025.

Is Ainos, Inc. profitable?

No, Ainos, Inc. (AIMD) reported a net income of -$14.8M in fiscal year 2025.

What is Ainos, Inc.'s EBITDA?

Ainos, Inc. (AIMD) had EBITDA of -$9.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Ainos, Inc.'s gross margin?

Ainos, Inc. (AIMD) had a gross margin of 82.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ainos, Inc.'s return on equity (ROE)?

Ainos, Inc. (AIMD) has a return on equity of -195.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ainos, Inc.'s free cash flow?

Ainos, Inc. (AIMD) recorded an outflow of $4.6M in free cash flow during fiscal year 2025. This represents a 20.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ainos, Inc.'s operating cash flow?

Ainos, Inc. (AIMD) recorded an outflow of $4.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Ainos, Inc.'s total assets?

Ainos, Inc. (AIMD) had $20.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ainos, Inc.'s capital expenditures?

Ainos, Inc. (AIMD) invested $35K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ainos, Inc. spend on research and development?

Ainos, Inc. (AIMD) invested $7.7M in research and development during fiscal year 2025.

How many shares does Ainos, Inc. have outstanding?

Ainos, Inc. (AIMD) had 7M shares outstanding as of fiscal year 2025.

What is Ainos, Inc.'s current ratio?

Ainos, Inc. (AIMD) had a current ratio of 1.06 as of fiscal year 2025, which is considered adequate.

What is Ainos, Inc.'s debt-to-equity ratio?

Ainos, Inc. (AIMD) had a debt-to-equity ratio of 1.76 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ainos, Inc.'s return on assets (ROA)?

Ainos, Inc. (AIMD) had a return on assets of -70.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ainos, Inc.'s P/E ratio?

Ainos, Inc. (AIMD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $8.9M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ainos, Inc.'s price-to-sales ratio?

Ainos, Inc. (AIMD) trades at 657x sales, its market capitalization divided by revenue of $14K revenue, trailing 12 months to June 30, 2026. The market capitalization is $8.9M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Ainos, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Ainos, Inc. (AIMD) held $417K in cash, cash equivalents and investments, and reported an operating cash outflow of $4.6M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Ainos, Inc.'s Altman Z-Score?

Ainos, Inc. (AIMD) has an Altman Z-Score of -6.33, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ainos, Inc.'s Piotroski F-Score?

Ainos, Inc. (AIMD) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ainos, Inc.'s earnings high quality?

Ainos, Inc. (AIMD) reported a net loss of $14.8M while operations used $4.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Ainos, Inc. cover its interest payments?

Ainos, Inc. (AIMD) reported an operating loss of $14.0M against $712K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.